Despite the recent rollout of Isoniazid Preventive Therapy (IPT) to prevent TB in people living with HIV in South Africa, adherence and completion rates are low. To explore barriers to IPT completion in rural KwaZulu-Natal, South Africa, we conducted individual semi-structured interviews among 30 HIV patients who had completed or defaulted IPT. Interview transcripts were analyzed according to the framework method of qualitative analysis. Facilitators of IPT completion included knowledge of TB and IPT, accepting one's HIV diagnosis, viewing IPT as similar to antiretroviral therapy, having social support in the community and the clinic, trust in the healthcare system, and desire for health preservation. Barriers included misunderstanding of IPT's preventive role in the absence of symptoms, inefficient health service delivery, ineffective communication with healthcare workers, financial burden of transport to clinic and lost wages, and competing priorities. HIVrelated stigma was not identified as a significant barrier to IPT completion, and participants felt confident in their ability to manage stigma, for example by pretending their medications were for unrelated conditions. Completers were more comfortable communicating with health care workers than were defaulters. Efforts to facilitate successful IPT completion must include appropriate counseling and education for individual patients and addressing inefficiencies within the health care system in order to minimize patients' financial and logistical burden. These patient-level and structural changes are necessary for IPT to successfully reduce TB incidence in this resource-limited setting.
Introduction
South Africa has one of the greatest HIV and tuberculosis (TB) burdens worldwide (World Health Organization, 2007) . Daily isoniazid for >6 months safely decreases active TB risk in HIV-positive patients by 60% (Akolo, Adetifa, Shepperd, & Volmink, 2010; Grant et al., 2010; van Halsema et al., 2010) . South African guidelines recommend isoniazid preventive therapy (IPT) for all HIV-positive patients without active TB symptoms, regardless of CD4 count, antiretroviral therapy (ART) status or prior TB history (Launch of 2013 Isoniazid Preventive Therapy Guidelines, 2013), yet completion rates are low (Chehab, Vilakazi-Nhlapo, Vranken, Peters, & Klausner, 2012) .
Previously reported barriers to IPT adherence and completion in resource-limited settings include HIV-related stigma (Makanjuola, Taddese, & Booth, 2014; Rowe et al., 2005) , recent HIV diagnosis (Oni et al., 2012) , male gender, poor understanding of IPT (Gust et al., 2011) , transportation and medication expenses, unstable housing, and unemployment (Codecasa et al., 2013; Rutherford et al., 2012) . Concurrent ART may predict IPT success (Durovni et al., 2010; Rutherford et al., 2012) .
Previous data on IPT adherence in South Africa were collected in the pre-ART era, within monitored clinical trials, or urban settings. Our qualitative investigation uniquely explores factors influencing IPT completion or default among HIV-positive patients in rural South Africa who initiated IPT during routine HIV care in the post-ART era.
Methods

Study setting
Msinga subdistrict's rural Zulu population largely survives on government welfare grants due to 80% unemployment; only half have access to electricity (KwaZulu-Natal uMzinyathi District Profile, 2012) . TB incidence (>1100/100,000) and HIV antenatal prevalence (31.1%) are high (The national antenatal sentinel HIV and Syphilis prevalence survey, 2010). A government district hospital and 15 satellite primary health care clinics (PHCs) provide free ART and IPT to HIV-positive patients.
Participant selection
Eligible participants were HIV-positive, ≥18 years, and had initiated IPT at the district hospital clinic or one of four select PHCs. We recruited male and female "completers" (collected IPT for >6 consecutive months and self-reported >80% adherence) and "defaulters" (collected IPT for <6 months) through purposive sampling. Potential participants were identified by clinic IPT registers and approached in waiting rooms or by telephone. Those willing to participate were privately screened for inclusion criteria and completer/defaulter status.
Qualitative data collection
In a private setting, a Zulu-speaking researcher (NM) obtained verbal consent and conducted one-on-one, hour-long semi-structured interviews exploring knowledge and attitudes towards TB, IPT, and HIV, and reasons for initiating IPT and completing/defaulting treatment. Two pilot interviews were conducted to refine question prompts and train the study team.
Yale University's Human Investigation Committee and the South African Medical Association Research Ethics Committee approved the protocol.
Data analysis
Transcribed audio recordings were professionally translated from Zulu to English. Data were analyzed with Atlas.ti qualitative analysis software using a framework approach (Pope, Ziebland, & Mays, 2000) . A starting code list was applied to a subset of interviews and code definitions refined iteratively. The lead author coded all interviews, and all authors coded select interviews. Coding discrepancies were resolved through group discussion. Codes were organized in a working analytic framework based on previously-developed theoretical models of IPT and TB treatment adherence (Makanjuola et al., 2014; Munro et al., 2007) then merged into subthemes and themes illustrating facilitators and barriers to IPT completion.
Results
Twelve male and 18 female participants were interviewed (Table 1) . Seventeen completed IPT, and 13 defaulted. Several distinct themes emerged ( Table 2 ).
Facilitators of IPT success
Knowledge and beliefs about TB and IPT Many participants feared TB. One-third had TB previously, and all knew someone with TB.
Most participants knew that IPT prevents TB. Some knew IPT is taken when asymptomatic. Others erroneously hoped it would alleviate present symptoms, prompting some to adhere but deterring others who were asymptomatic and doubted IPT's value.
Accepting one's HIV diagnosis
When discussing IPT, many participants first described their HIV history. Accepting their HIV diagnosis and beginning ART facilitated deciding to begin IPT.
Similarity of IPT and ART
IPT was viewed as similar to ART. Participants already accustomed to daily ART regarded one additional daily pill as trivial. All but 3 (2 completers, 1 defaulter) took IPT concurrently with ART.
Social support
Family, friends and coworkers of both completers and defaulters lent money for transport to clinic, collected treatment refills, provided childcare, and covered for absent employees. They also provided information about HIV, TB and IPT, encouragement to seek treatment, and reminders to take pills. Fear of transmitting TB to loved ones motivated adherence for both groups.
Many completers befriended fellow patients in clinic waiting rooms and exchanged information about medications and side effects. No defaulters described such interactions.
Coping with stigma Participants acknowledged community stigma against HIV, but not TB. No participants named HIV-related stigma as a barrier to IPT. Many participants felt no need to hide their medications, believing only other HIV patients would connect IPT with HIV. Completers and defaulters did not differ in describing stigma.
Health preservation
All interviewees were motivated to remain alive and healthy and willing to take medication despite barriers.
Trust in healthcare system
Both completers and defaulters trusted providers and followed instructions carefully. However, more completers than defaulters trusted clinic staff to respond supportively to their concerns.
Barriers to IPT success
Expense of accessing health care Monthly transport to clinics was often expensive, and many participants had to forego income to attend appointments. Economic difficulties underlay most treatment interruptions. Prioritizing ART over IPT Facing obstacles, patients were more likely to default IPT, but not ART. All but one defaulter continued to take ART even when interrupting IPT.
Discussion
This is the first study to qualitatively examine barriers to IPT completion in programmatic health care settings in rural South Africa in the post-ART era. Consistent with existing literature, expense of clinic visits and inefficient health care delivery were major barriers. Our unique findings include the importance of accepting one's HIV diagnosis for IPT success, absence of HIV-related stigma as a barrier to successful IPT completion, and prioritization of ART over IPT. Completers and defaulters differed in how they experienced social support and comfort with clinic staff in handling setbacks. Figure 1 illustrates major themes of health determinants relevant to our findings, and their reciprocal influence. These findings inform strategies to facilitate successful IPT completion at the provider, facility and policy levels ( Table 3) . Participants viewed IPT through the lens of their HIV diagnosis and treatment and many had trouble separating the two. Often, the major barrier to IPT had been entering HIV care. Once on lifelong ART, IPT's marginal cost was low. Other studies have identified recent HIV diagnosis as a barrier (Oni et al., 2012) and concurrent ART as a facilitator (Durovni et al., 2010; Rutherford et al., 2012) to IPT completion. Newly diagnosed patients or those not yet on ART may require extra support before beginning IPT.
HIV-related stigma did not emerge as a specific barrier to IPT, and participants strategized successfully to avoid consequences of stigma while accessing HIV care and IPT. Stigma may remain a significant barrier among those not yet engaged in care.
While pill burden may discourage IPT adherence elsewhere (Mindachew, Deribew, Tessema, & Biadgilign, 2011) , our study participants generally accepted one extra tablet. However, ART took priority over IPT, and all 12 IPT defaulters continued ART without interruption. Selective adherence to ART over active TB treatment has also been described (Daftary, Padayatchi, & O'Donnell, 2014) . Integrating ART and IPT delivery may decrease the incremental burden of IPT, facilitating longer IPT duration according to recently updated guidelines (National Tuberculosis Management Guidelines, 2014) .
Incomplete knowledge is sometimes a barrier to IPT completion (Ngamvithayapong, Uthaivoravit, Yanai, Figure 1 . Facilitators and barriers to IPT adherence among HIV patients accessing HIV care in rural KZN, South Africa. IPT = Isoniazid preventive therapy, KAP = Knowledge, attitudes, practices, TB = Tuberculosis. In order to adhere to IPT, patients must have accepted their HIV diagnosis and be in a social situation in which they either feel comfortable disclosing their status or feel that they can manage their social situation to keep their status hidden. Patients must trust that the health care system will not only provide effective medical care but also will empower them to communicate effectively with providers so that any questions or problems such as side effects can be addressed. They must have the ability and resources (transport fare, a job that allows time off) to physically access care including getting to clinic appointments and taking pills consistently. They must believe that TB is a risk even if they are asymptomatic and that IPT will reduce that risk without adverse effects, and they must make health a priority. These concepts influence each other; for example, trust in health system is also necessary for HIV testing and diagnosis; presence of social support can mitigate economic burdens; knowledge and beliefs about IPT come from both social networks and within the health system; sometimes the desire for health preservation is outweighed by immediate lack of resources to survive.
Akarasewi, & Sawanpanyalert, 1997). Misunderstanding the prophylaxis concept can de-motivate asymptomatic patients (Gust et al., 2011) . Poor understanding of IPT's intended duration was only a barrier when clinic staff erred. IPT counseling should be tailored to the patient's education level (Lester et al., 2010; Mindachew et al., 2011) , perhaps using public holidays to help patients mark projected treatment end dates, and emphasizing that preventive medications are taken when asymptomatic.
Expense and inconvenience of collecting medications often led to IPT interruptions. Long queues, drug stockouts, and lack of service integration are unfortunately commonplace in resource-limited settings (Munro et al., 2007) , particularly PHCs (Szakacs et al., 2006) , and require attention on an institution and policy level. Fear of speaking up to clinic staff often hindered problem-solving. Providers should empower patients to ask questions and report problems. Increasing the interval between clinic visits for stable patients and facilitating transfer of care between clinics may ease these burdens.
Despite barriers, motivation to preserve health was universal. Financial, logistic and emotional social support helped mitigate treatment barriers.
Our findings may not be generalizable to other settings, or to HIV-positive patients not yet in care. However, they are particularly relevant to rural South African patients already accessing HIV care and eligible for IPT.
Conclusion
For HIV-positive patients already engaged in care, IPT success depends on accepting one's HIV diagnosis, social support, trust in healthcare system and desire for health preservation. Addressing economic and logistical difficulties, inefficient health care delivery and suboptimal patient-provider communication may facilitate patients' completion of IPT and further this strategy's impact on reducing TB incidence in resource-limited settings. Table 3 . Recommendations for increasing access to IPT among HIV patients accessing care at clinics in rural South Africa.
Level of Action Recommendation
Provider In addition to a thorough review of the benefits and risks of IPT, education and pre-counseling of patients initiating IPT should specifically include the following information, presented according to the patient's level of health literacy. . IPT is for TB prevention and is not meant to alleviate symptoms . The correct duration of IPT (based on up-to-date guidelines) . Potential side effects, as some are treatable with pyridoxine . Encourage reporting of complaints/problems . Is the patient planning to travel or otherwise cannot attend monthly visits? . Is the patient struggling with a new HIV diagnosis, or not yet on ART, and in need of further counseling before entering into care?
Health Facility
. Ensure continuous supply of medication . Policy of giving >2 months' supply of medication for patients who are stable and will travel . Integration of care (patients pick up ART and IPT at same time and location within clinic)
Policy . Facilitate transfers between clinics in different cities, provinces
Notes: Barriers to successful IPT completion can be minimized, and facilitators enhanced, by specific actions at the provider, facility, and policy levels.
